Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
Brief Summary: This study will compare the effectiveness of cognitive behavioral therapy
(CBT), lisdexamfetamine (LDX), and the combination of CBT and LDX for the treatment of
binge-eating disorder in patients with obesity. This is an acute treatment comparing CBT or
LDX alone or in combination.
Phase:
Phase 3
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)